Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBloating is one of the most commonly reported side effects of Mounjaro, affecting a significant proportion of users during the early weeks of treatment. It happens because tirzepatide slows the rate at which the stomach empties — a deliberate part of how the medicine reduces appetite — and that slower transit can leave gas and pressure building in the abdomen. For most people, the bloating is worst in the first few days after a new dose or a dose increase, then eases as the gut adjusts. Mounjaro is a prescription-only medicine, and a GPhC-registered prescriber will assess your full picture before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates two gut-hormone receptors (GIP and GLP-1) that together slow the pace at which food moves from the stomach into the small intestine. This is documented in the clinical programme data and reflected in the NHS's patient information for tirzepatide. The slower food sits in the stomach, the more gas accumulates and the greater the sensation of fullness and pressure. It is not a malfunction; it is the same mechanism that suppresses appetite and drives weight loss. That does not make it comfortable, but it does mean the bloating Mounjaro causes is usually predictable and manageable rather than a sign that something has gone wrong.
In the SURMOUNT-1 trial (2,539 adults with obesity, 72 weeks) gastrointestinal side effects including abdominal distension were among the most frequently reported events, particularly in the early escalation phase. The pattern across the trial was that GI symptoms peaked around dose changes and declined with time at a stable dose. If you want the broader picture of how tirzepatide works, the tirzepatide overview covers the mechanism in more depth.
The bloating most people experience follows a recognisable rhythm. It tends to arrive within a day or two of the first injection or a step up in dose, peaks somewhere between 48 and 72 hours, and then softens over the following week as the gut adapts to the new signal load. People who are sensitive to GI effects sometimes find the adjustment takes a full two weeks at a new strength. After that, many find they barely notice it at stable doses.
The timing of your weekly injection can make a practical difference. Some people find scheduling their injection for a Friday evening means the worst of the bloating lands over the weekend rather than mid-week at work. Others time it around quieter patches, not the day before a long drive or a big dinner. It is a small adjustment, but one our prescribers hear about regularly from people who have found it genuinely useful. For a detailed look at why the bloating persists in some cases, this page explores the reasons some people find it more stubborn.
If you are still in the early weeks of treatment and feeling bloated on Mounjaro feels significant right now, it is worth bearing in mind that the experience often changes substantially once the dose stabilises. Reporting it to your prescriber rather than stopping treatment is nearly always the right first step.
Several adjustments consistently reduce the severity of bloating for people on tirzepatide, and they do not require any change to the medicine itself.
Portion size is probably the single most effective lever. Mounjaro reduces appetite, but if meals are still structured around pre-treatment portion sizes, the slowed stomach simply cannot keep up. Smaller, more frequent meals distribute the digestive load. Eating slowly and chewing thoroughly reduces the amount of air swallowed with food, a surprisingly significant contributor to gas on a slowed gut. Highly carbonated drinks add gas directly; cutting them out during the first weeks at a new dose is low effort and often noticeably helpful.
High-fat and very rich foods slow gastric emptying further, compounding what tirzepatide is already doing. This does not mean avoiding fat entirely, but oily takeaways and large portions of fried food on injection day tend to make the bloating worse. The full Mounjaro guide includes more on supporting the medicine with practical diet changes.
Walking after meals keeps the gut moving. Even a 10-minute walk stimulates gut motility and can meaningfully reduce the pressure. Peppermint tea has some evidence for easing intestinal spasm and is a harmless addition. If over-the-counter antacids or simethicone-containing products help, they are generally compatible, but check with your prescriber or pharmacist first, particularly if you take other medicines with the tablet form.
Most bloating on Mounjaro is an inconvenience, not a danger. There are signals, though, that warrant prompt medical attention. Bloating accompanied by severe abdominal pain that spreads to the back, especially with vomiting, should not be waited out: the MHRA's January 2026 Drug Safety Update on GLP-1 medicines specifically named acute pancreatitis as a known, infrequent but serious risk, and the symptom pattern for pancreatitis is exactly that combination. You can report unexpected or serious reactions at the MHRA's Yellow Card scheme.
Persistent bloating with signs of significant dehydration (dark urine, dizziness, inability to keep fluids down) also needs a GP call or 111, because severe GI illness on a GLP-1 can accelerate dehydration faster than people expect.
For bloating that is uncomfortable but not alarming, questions about dose timing, whether to slow the titration schedule, or whether your current strength is right for you all belong in a prescriber conversation. If you are already a patient and want to discuss how you are getting on, the contact page reaches our aftercare team seven days a week. Or, if you are still considering treatment and weighing up what the side-effect profile really looks like day to day, speaking to our prescribers is a good place to start, the consultation is free and reviewed the same day by a named clinician.
For those thinking about the cost side of treatment alongside the clinical picture, a plain-English breakdown of what Mounjaro actually costs through a legitimate UK pharmacy is worth reading before making a decision.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.